1.11 USD
↘ 0.04 (3.48%)AT CLOSE (11:59 AM EDT)
Cardiol Therapeutics Inc. Class A Common Shares
CRDLNASDAQ • USD
1.12
↗ 0.01 (0.90%)
POST MARKET (AS OF 07:07 PM EDT)
Post Market
AS OF 07:07 PM EDT
1.12
↗ 0.01 (0.90%)
Market: CLOSED
Open?$1.12
High?$1.16
Low?$1.10
Prev. Close?$1.15
Volume?427.4K
Avg. Volume?N/A
VWAP?$1.13
Bid / Ask
Bid?$1.11 × 500
Ask?$1.12 × 1.0K
Spread?$0.01
Midpoint?$1.12
Valuation & Ratios
Market Cap?128.0M
Shares Out?115.2M
Float?108.3M
Float %?97.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
CRDL is currently priced at $1.11. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?1.81%Low
Short Interest?2.0M
Days to Cover?4.5
Free Float108.3M
Avg Daily Volume439.4K
Settlement Date2026-05-15